United States Drug-Eluting Stents Market Report 2016

Name: United States Drug-Eluting Stents Market Report 2016
Brand: QYResearch
SKU: U35121B3D31EN
Price: 3800 USD
Availability: InStock

December 2016 | 104 pages | ID: U35121B3D31EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Notes:

Sales, means the sales volume of Drug-Eluting Stents

Revenue, means the sales value of Drug-Eluting Stents

This report studies sales (consumption) of Drug-Eluting Stents in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Abbott Vascular (USA)
Boston Scientific, Inc. (USA)
Biosensors International Pte Ltd. (Singapore)
Medtronic, Inc.(USA)
MIV Therapeutics, Inc. (Canada)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I
Type II
Type III

Split by applications, this report focuses on sales, market share and growth rate of Drug-Eluting Stents in each application, can be divided into

Application 1
Application 2
Application 3

United States Drug-Eluting Stents Market Report 2016

1 DRUG-ELUTING STENTS OVERVIEW

1.1 Product Overview and Scope of Drug-Eluting Stents
1.2 Classification of Drug-Eluting Stents
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Drug-Eluting Stents
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drug-Eluting Stents (2011-2021)
  1.4.1 United States Drug-Eluting Stents Sales and Growth Rate (2011-2021)
  1.4.2 United States Drug-Eluting Stents Revenue and Growth Rate (2011-2021)

2 UNITED STATES DRUG-ELUTING STENTS COMPETITION BY MANUFACTURERS

2.1 United States Drug-Eluting Stents Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drug-Eluting Stents Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drug-Eluting Stents Average Price by Manufactures (2015 and 2016)
2.4 Drug-Eluting Stents Market Competitive Situation and Trends
  2.4.1 Drug-Eluting Stents Market Concentration Rate
  2.4.2 Drug-Eluting Stents Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRUG-ELUTING STENTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Drug-Eluting Stents Sales and Market Share by Type (2011-2016)
3.2 United States Drug-Eluting Stents Revenue and Market Share by Type (2011-2016)
3.3 United States Drug-Eluting Stents Price by Type (2011-2016)
3.4 United States Drug-Eluting Stents Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DRUG-ELUTING STENTS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Drug-Eluting Stents Sales and Market Share by Application (2011-2016)
4.2 United States Drug-Eluting Stents Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DRUG-ELUTING STENTS MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbott Vascular (USA)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Drug-Eluting Stents Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbott Vascular (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Boston Scientific, Inc. (USA)
  5.2.2 Drug-Eluting Stents Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Biosensors International Pte Ltd. (Singapore)
  5.3.2 Drug-Eluting Stents Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Medtronic, Inc.(USA)
  5.4.2 Drug-Eluting Stents Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Medtronic, Inc.(USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 MIV Therapeutics, Inc. (Canada)
  5.5.2 Drug-Eluting Stents Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview

6 DRUG-ELUTING STENTS MANUFACTURING COST ANALYSIS

6.1 Drug-Eluting Stents Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Drug-Eluting Stents

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Drug-Eluting Stents Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Drug-Eluting Stents Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DRUG-ELUTING STENTS MARKET FORECAST (2016-2021)

10.1 United States Drug-Eluting Stents Sales, Revenue Forecast (2016-2021)
10.2 United States Drug-Eluting Stents Sales Forecast by Type (2016-2021)
10.3 United States Drug-Eluting Stents Sales Forecast by Application (2016-2021)
10.4 Drug-Eluting Stents Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Picture of Drug-Eluting Stents
Table Classification of Drug-Eluting Stents
Figure United States Sales Market Share of Drug-Eluting Stents by Type in 2015
Table Application of Drug-Eluting Stents
Figure United States Sales Market Share of Drug-Eluting Stents by Application in 2015
Figure United States Drug-Eluting Stents Sales and Growth Rate (2011-2021)
Figure United States Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Table United States Drug-Eluting Stents Sales of Key Manufacturers (2015 and 2016)
Table United States Drug-Eluting Stents Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drug-Eluting Stents Sales Share by Manufacturers
Figure 2016 Drug-Eluting Stents Sales Share by Manufacturers
Table United States Drug-Eluting Stents Revenue by Manufacturers (2015 and 2016)
Table United States Drug-Eluting Stents Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drug-Eluting Stents Revenue Share by Manufacturers
Table 2016 United States Drug-Eluting Stents Revenue Share by Manufacturers
Table United States Market Drug-Eluting Stents Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drug-Eluting Stents Average Price of Key Manufacturers in 2015
Figure Drug-Eluting Stents Market Share of Top 3 Manufacturers
Figure Drug-Eluting Stents Market Share of Top 5 Manufacturers
Table United States Drug-Eluting Stents Sales by Type (2011-2016)
Table United States Drug-Eluting Stents Sales Share by Type (2011-2016)
Figure United States Drug-Eluting Stents Sales Market Share by Type in 2015
Table United States Drug-Eluting Stents Revenue and Market Share by Type (2011-2016)
Table United States Drug-Eluting Stents Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drug-Eluting Stents by Type (2011-2016)
Table United States Drug-Eluting Stents Price by Type (2011-2016)
Figure United States Drug-Eluting Stents Sales Growth Rate by Type (2011-2016)
Table United States Drug-Eluting Stents Sales by Application (2011-2016)
Table United States Drug-Eluting Stents Sales Market Share by Application (2011-2016)
Figure United States Drug-Eluting Stents Sales Market Share by Application in 2015
Table United States Drug-Eluting Stents Sales Growth Rate by Application (2011-2016)
Figure United States Drug-Eluting Stents Sales Growth Rate by Application (2011-2016)
Table Abbott Vascular (USA) Basic Information List
Table Abbott Vascular (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Vascular (USA) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Boston Scientific, Inc. (USA) Basic Information List
Table Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Biosensors International Pte Ltd. (Singapore) Basic Information List
Table Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Medtronic, Inc.(USA) Basic Information List
Table Medtronic, Inc.(USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic, Inc.(USA) Drug-Eluting Stents Sales Market Share (2011-2016)
Table MIV Therapeutics, Inc. (Canada) Basic Information List
Table MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Stents
Figure Manufacturing Process Analysis of Drug-Eluting Stents
Figure Drug-Eluting Stents Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Stents Major Manufacturers in 2015
Table Major Buyers of Drug-Eluting Stents
Table Distributors/Traders List
Figure United States Drug-Eluting Stents Production and Growth Rate Forecast (2016-2021)
Figure United States Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Table United States Drug-Eluting Stents Production Forecast by Type (2016-2021)
Table United States Drug-Eluting Stents Consumption Forecast by Application (2016-2021)

United States Drug-Eluting Stents Market Report 2016

More Publications

Need Help?

Ask a Question

Market Reports